Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

2-Thiopyrimidine/chalcone hybrids: design, synthesis, ADMET prediction, and anticancer evaluation as STAT3/STAT5a inhibitors
Phoebe F. Lamie, John N. Philoppes
Journal of Enzyme Inhibition and Medicinal Chemistry (2020) Vol. 35, Iss. 1, pp. 864-879
Open Access | Times Cited: 24

Showing 24 citing articles:

Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation
Jinyun Dong, Xiangdong Cheng, Weidong Zhang, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 13, pp. 8884-8915
Closed Access | Times Cited: 138
Targeting JAK2/STAT3 for the treatment of cancer: A review on recent advancements in molecular development using structural analysis and SAR investigations
Rupali Kohal, Priya Bisht, Ghanshyam Das Gupta, et al.
Bioorganic Chemistry (2024) Vol. 143, pp. 107095-107095
Closed Access | Times Cited: 13
A comprehensive review on pyrimidine analogs-versatile scaffold with medicinal and biological potential
N. Jeelan Basha, Naganna M. Goudgaon
Journal of Molecular Structure (2021) Vol. 1246, pp. 131168-131168
Closed Access | Times Cited: 91
Targeting STAT3 and NF-κB Signaling Pathways in Cancer Prevention and Treatment: The Role of Chalcones
Violetta Krajka‐Kuźniak, Marta Belka, Katarzyna Papierska
Cancers (2024) Vol. 16, Iss. 6, pp. 1092-1092
Open Access | Times Cited: 9
Optimization of pyrazole-based compounds with 1,2,4-triazole-3-thiol moiety as selective COX-2 inhibitors cardioprotective drug candidates: Design, synthesis, cyclooxygenase inhibition, anti-inflammatory, ulcerogenicity, cardiovascular evaluation, and molecular modeling studies
Khaled R.A. Abdellatif, Eman K. A. Abdelall, Heba A.H. Elshemy, et al.
Bioorganic Chemistry (2021) Vol. 114, pp. 105122-105122
Closed Access | Times Cited: 35
Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study
Tarek S. Ibrahim, Ahmad J. Almalki, Amr H. Moustafa, et al.
Bioorganic Chemistry (2021) Vol. 111, pp. 104885-104885
Closed Access | Times Cited: 31
Piperazine-derived small molecules as potential Flaviviridae NS3 protease inhibitors. In vitro antiviral activity evaluation against Zika and Dengue viruses
María del Rosario García-Lozano, Filippo Dragoni, Paloma Gallego, et al.
Bioorganic Chemistry (2023) Vol. 133, pp. 106408-106408
Open Access | Times Cited: 11
Recent Progresses in Chalcone Derivatives as Potential Anticancer Agents
Jiahui Yang, Jianmei Lv, Shuxian Cheng, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 11, pp. 1265-1283
Closed Access | Times Cited: 10
Identification of chalcone analogues as anti-inflammatory agents through the regulation of NF-κB and JNK activation
Die Zhang, Wenping Wang, Huiping Ou, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 6, pp. 2002-2017
Closed Access | Times Cited: 3
One‐potandtwo‐potmethods for chalcone derived pyrimidines synthesis and applications
Saba Farooq, Zainab Ngaini
Journal of Heterocyclic Chemistry (2021) Vol. 58, Iss. 6, pp. 1209-1224
Open Access | Times Cited: 24
Novel chalcone/aryl carboximidamide hybrids as potent anti-inflammatory via inhibition of prostaglandin E2 and inducible NO synthase activities: design, synthesis, molecular docking studies and ADMET prediction
Tarek S. Ibrahim, Amr H. Moustafa, Ahmad J. Almalki, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1067-1078
Open Access | Times Cited: 24
Synthesis, Anticancer Assessment, and Molecular Docking of Novel Chalcone-Thienopyrimidine Derivatives in HepG2 and MCF-7 Cell Lines
Ghada Mohamed Safwat, Kamel M. A. Hassanin, Eman T. Mohammed, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 22
Discovery of STAT3 Inhibitors: Recent Advances and Future Perspectives
Jiatao Song, Jiawei Wang, Sheng Tian, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 16, pp. 1824-1847
Closed Access | Times Cited: 14
Design, synthesis, and pharmacological evaluation of novel and selective COX-2 inhibitors based on celecoxib scaffold supported with in vivo anti-inflammatory activity, ulcerogenic liability, ADME profiling and docking study
Khaled R.A. Abdellatif, Eman K. A. Abdelall, Heba A.H. Elshemy, et al.
Bioorganic Chemistry (2022) Vol. 120, pp. 105627-105627
Closed Access | Times Cited: 12
Discovery of orally active chalcones as histone lysine specific demethylase 1 inhibitors for the treatment of leukaemia
Yang Li, Ying Sun, Yang Zhou, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2020) Vol. 36, Iss. 1, pp. 207-217
Open Access | Times Cited: 11
Design, synthesis, and anti-hepatocellular carcinoma of thiopyrimidine/chalcone hybrids as dual STAT3/STAT5 inhibitors
Najla Altwaijry, Rehab Sabour, Mona H. Ibrahim, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 10, pp. 1981-1991
Open Access | Times Cited: 2
Repurposing Study of 4-Acyl-1-phenylaminocarbonyl-2-substituted-piperazine Derivatives as Potential Anticancer Agents—In Vitro Evaluation against Breast Cancer Cells
Emilio Guillén-Mancina, María del Rosario García-Lozano, Estefanía Burgos‐Morón, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 17041-17041
Open Access | Times Cited: 2
Design, synthesis and in vitro biological evaluation of a novel class of anti-adenovirus agents based on 3-amino-1,2-propanediol
Sarah Mazzotta, Judith Berastegui‐Cabrera, Margarita Vega‐Holm, et al.
Bioorganic Chemistry (2021) Vol. 114, pp. 105095-105095
Open Access | Times Cited: 6
Novel pyrazole-oxadiazole hybrids possessing methanesulphonyl pharmacophore with good gastric safety profile: Design, synthesis, cyclooxygenase inhibition, anti-inflammatory activity and histopathological studies
Khaled R.A. Abdellatif, Eman K. A. Abdelall, Phoebe F. Lamie, et al.
Journal of Molecular Structure (2022) Vol. 1266, pp. 133529-133529
Closed Access | Times Cited: 3
Anticancer Cytotoxic Activity of Bispidine Derivatives Associated with the Increasing Catabolism of Polyamines
Ekaterina Neborak, Altynay B. Kaldybayeva, Lylia Bey, et al.
Molecules (2022) Vol. 27, Iss. 12, pp. 3872-3872
Open Access | Times Cited: 3
Identification and Prioritization of PET Neuroimaging Targets for Microglial Phenotypes Associated with Microglial Activity in Alzheimer’s Disease
Nicole D. Bartolo, Niall Mortimer, Mariah A. Manter, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 24, pp. 3641-3660
Closed Access | Times Cited: 3
A New Approach for Synthesis of 2-Thioxocytosine-5-carbonitrile as Antimicrobial Agents
Samar M. Mohammed, Ahmed H. Moustafa, Hassan A. El‐Sayed, et al.
Russian Journal of General Chemistry (2022) Vol. 92, Iss. 9, pp. 1806-1813
Closed Access | Times Cited: 2
synthesis and characterization of Pyrimidine from chalcone as a polymeric prodrug with fusidic acid and ZnO and study bioactivity
Muhsn Ali hazam, Raheem Jameel Mahesein, H Al-Salman
Journal of Population Therapeutics and Clinical Pharmacology (2023) Vol. 30, Iss. 5
Open Access
A new approach to pyrimidine-type heterocycles based on Petrenko–Kritschenko synthesis
Tung H. To, Dang B. Tran, Thang C. Pham, et al.
Chemistry of Heterocyclic Compounds (2022) Vol. 58, Iss. 11, pp. 608-614
Closed Access
Page 1

Scroll to top